Alkeon Capital Management - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 124 filers reported holding MERSANA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$16,973,000
-30.8%
1,799,838
-0.4%
0.03%
-19.4%
Q2 2021$24,529,000
-16.3%
1,806,267
-0.2%
0.04%
-18.2%
Q1 2021$29,294,000
-39.0%
1,810,505
+0.3%
0.04%
-43.6%
Q4 2020$48,027,000
+66.4%
1,804,828
+16.4%
0.08%
+47.2%
Q3 2020$28,861,0001,550,0000.05%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 5,000,000$6,350,0001.92%
VR Adviser, LLC 11,328,000$14,386,5601.51%
Bain Capital Life Sciences Investors, LLC 8,663,673$11,002,8651.23%
Affinity Asset Advisors, LLC 2,850,000$3,619,5001.02%
EcoR1 Capital, LLC 19,364,688$24,593,1540.83%
Altium Capital Management LP 1,059,136$1,345,1030.70%
5AM Venture Management, LLC 1,305,000$1,657,3500.48%
Decheng Capital Management III (Cayman), LLC 904,268$1,148,4200.38%
COMMODORE CAPITAL LP 2,244,378$2,850,3600.33%
Philosophy Capital Management LLC 2,342,634$2,975,1450.32%
View complete list of MERSANA THERAPEUTICS INC shareholders